These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 400716)

  • 1. Presence of insulin-renin-aldosterone-potassium interrelationship in normal subjects, disrupted in chronic hemodialysis patients.
    Farfel Z; Iaina A; Eliahou HE
    J Clin Endocrinol Metab; 1978 Jul; 47(1):9-17. PubMed ID: 400716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
    Schambelan M; Brust NL; Chang BC; Slater KL; Biglieri EG
    J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A; Weidmann P; Shaw S; Gnädinger M
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone response to insulin-induced hypoglycemia in hemodialysis patients.
    Ramirez G; Ganguly A; Bruegemeyer C; Gomez-Sanchez C
    Am J Nephrol; 1989; 9(3):215-21. PubMed ID: 2547316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Uhlschmid G; Furrer J; Siegenthaler W
    Clin Nephrol; 1976 Oct; 6(4):433-6. PubMed ID: 788978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man.
    Weinberger MH; Kem DC; Gomez-Sanchez C; Kramer NJ; Martin BT; Nugent CA
    J Lab Clin Med; 1975 Jun; 85(6):957-67. PubMed ID: 166119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis.
    Farinelli A; Squerzanti R; De Paoli Vitali E; Bagni B; Cavallini AR; Gilli P; Bedani PL
    Nephron; 1980; 26(6):274-9. PubMed ID: 7005702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal renin-aldosterone-insulin and potassium interrelationship in FMF patients and amyloid nephropathy.
    Shemer J; Royburt M; Cabili S; Iaina A; Pras M; Eliahou H
    Ren Fail; 1992; 14(4):555-62. PubMed ID: 1462007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
    Novo S; Adamo L; Forte G; Galfano G; Giamporcaro A; Ferrara D; Strano A
    Cardiologia; 1985 Jul; 30(7):505-10. PubMed ID: 3011264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
    Krimkevich EI; Petrun' NM; Baran EIa; Kutsaĭ NN; Khomenko NV
    Ter Arkh; 1986; 58(8):81-4. PubMed ID: 3020729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronism.
    Beretta-Piccoli C; Weidmann P; Bianchetti MG; Brown JJ; Fraser R; Lever AF; Link L; Robertson JI
    Clin Exp Hypertens A; 1982; 4(9-10):1541-58. PubMed ID: 6754145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B; Henriet MT
    Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG; Espiner EA; Donald RA
    J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of aldosterone responsiveness in terminal renal failure.
    Weidmann P; Maxwell MH; De Lima J; Hirsch D; Franklin SS
    Kidney Int; 1975 May; 7(5):351-7. PubMed ID: 166231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma aldosterone in chronic renal insufficiency and in anephric patients (author's transl)].
    Botey A; Bestard J; Mauri M; López Pedret J; Revert L
    Med Clin (Barc); 1979 Jul; 73(3):94-102. PubMed ID: 470511
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of plasma aldosterone during hemodialysis.
    Krämer BK; Ulshöfer TM; Müller GA; Ress KM; Risler T
    Int J Artif Organs; 1990 Jan; 13(1):32-8. PubMed ID: 2394492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
    Sciarra F; Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Concolino G
    Horm Res; 1977; 8(3):129-38. PubMed ID: 903075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.